Infectious Diseases

Developing Medicines for Infectious Diseases

60° Pharmaceuticals (60P) continues to fulfill its promise of developing medicines for infectious diseases. Such diseases include COVID-19, babesiosis, fungal diseases, malaria, and dengue fever.* Despite competitive drug development pipelines for these diseases, critical gaps remain.

*ARAKODA has not been reviewed or approved by the U.S. Food and Drug Administration for the treatment or prevention of COVID-19, babesiosis, dengue, or fungal diseases.

Cases and 1 Million+ deaths in the U.S. from COVID-19 infections


Annual deaths from malaria globally


Travelers to malaria endemic regions per annum


Annual dengue infections globally


1025 Connecticut Ave. NW, Suite 1000, Washington, DC 20036